Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder.

Published on Jun 10, 2021in Radiotherapy and Oncology4.856
· DOI :10.1016/J.RADONC.2021.06.011
Jonathan Khalifa11
Estimated H-index: 11
,
Stéphane Supiot29
Estimated H-index: 29
+ 17 AuthorsOlivier Riou7
Estimated H-index: 7
Sources
Abstract
Abstract null null Purpose null Curative radio-chemotherapy is recognized as a standard treatment option for muscle-invasive bladder cancer (MIBC). Nevertheless, the technical aspects for MIBC radiotherapy are heterogeneous with a lack of practical recommendations. null null null Methods and Materials null In 2018, a workshop identified the need for two cooperative groups to develop consistent, evidence-based guidelines for irradiation technique in the delivery of curative radiotherapy. Two radiation oncologists performed a review of the literature addressing several topics relative to radical bladder radiotherapy: planning computed tomography acquisition, target volume delineation, radiation schedules (total dose and fractionation) and dose delivery (including radiotherapy techniques, image-guided radiotherapy (IGRT) and adaptive treatment modalities). Searches for original and review articles in the PubMed and Google Scholar databases were conducted from January 1990 until March 2020. During a meeting conducted in October 2020, results on 32 topics were presented and discussed with a working group involving 15 radiation oncologists, 3 urologists and one medical oncologist. We applied the American Urological Association guideline development’s method to define a consensus strategy. null null null Results null A consensus was obtained for all 34 except 4 items. The group did not obtain an agreement on CT enhancement added value for planning, PTV margins definition for empty bladder and full bladder protocols, and for pelvic lymph-nodes irradiation. High quality evidence was shown in 6 items; 8 items were considered as low quality of evidence. null null null Conclusion null The current recommendations propose a homogenized modality of treatment both for routine clinical practice and for future clinical trials, following the best evidence to date, analyzed with a robust methodology. The XXX group formulates practical guidelines for the implementation of innovative techniques such as adaptive radiotherapy.
📖 Papers frequently viewed together
14 Citations
2 Authors (A E F Roy, P Wells)
12 Citations
120 Citations
References153
Newest
#1Rodrigo Rodrigues Pessoa (CU: University of Colorado Boulder)H-Index: 1
#2Adam C. Mueller (CU: University of Colorado Boulder)H-Index: 11
Last. Simon P. Kim (CU: University of Colorado Boulder)H-Index: 39
view all 10 authors...
Abstract INTRODUCTION Radiation therapy (XRT) has been investigated as a possible treatment for high-risk non-muscle invasive bladder cancer (NMIBC) with the goal of bladder preservation, especially with the ongoing Bacillus Calmette-Guerin (BCG) shortage. Yet, little is known about the clinical efficacy and the quality of evidence supporting XRT for NMIBC. Herein, we performed a systematic review and meta-analysis to evaluate XRT in the treatment of patients with high-risk NMIBC. METHODS Cochra...
1 CitationsSource
#1Ananya Choudhury (University of Manchester)H-Index: 28
#2Nuria Porta (ICR: Institute of Cancer Research)H-Index: 12
Last. Bcon investigatorsH-Index: 1
view all 13 authors...
Summary Background Two radiotherapy fractionation schedules are used to treat locally advanced bladder cancer: 64 Gy in 32 fractions over 6·5 weeks and a hypofractionated schedule of 55 Gy in 20 fractions over 4 weeks. Long-term outcomes of these schedules in several cohort studies and case series suggest that response, survival, and toxicity are similar, but no direct comparison has been published. The present study aimed to assess the non-inferiority of 55 Gy in 20 fractions to 64 Gy in 32 fra...
15 CitationsSource
#1J. Alfred Witjes (Radboud University Nijmegen Medical Centre)H-Index: 88
#2H.M. BruinsH-Index: 3
Last. Antoine G. van der Heijden (Radboud University Nijmegen Medical Centre)H-Index: 23
view all 15 authors...
Abstract Context This overview presents the updated European Association of Urology (EAU) guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective To provide practical evidence-based recommendations and consensus statements on the clinical management of MMIBC with a focus on diagnosis and treatment. Evidence acquisition A broad and comprehensive scoping exercise covering all areas of the MMIBC guideline has been performed annually since its 2017 publication (based on the 2...
204 CitationsSource
#1Morgan Rouprêt (University of Paris)H-Index: 74
#2Géraldine PignotH-Index: 23
Last. Y. NeuzilletH-Index: 8
view all 12 authors...
Summary Objective. - To update French guidelines for the management of bladder cancer specifically non-muscle invasive (NMIBC) and muscle-invasive bladder cancers (MIBC). Methods. - A Medline search was achieved between 2018 and 2020, notably regarding diagnosis, options of treatment and follow-up of bladder cancer, to evaluate different references with levels of evidence. Results. - Diagnosis of NMIBC (Ta, T1, CIS) is based on a complete deep resection of the tumor. The use of fluorescence and ...
3 CitationsSource
#1William A. Hall (MCW: Medical College of Wisconsin)H-Index: 23
#2Eric S. Paulson (MCW: Medical College of Wisconsin)H-Index: 19
Last. Colleen A. Lawton (MCW: Medical College of Wisconsin)H-Index: 61
view all 25 authors...
Purpose In 2009, the Radiation Therapy Oncology Group (RTOG) genitourinary members published a consensus atlas for contouring prostate pelvic nodal clinical target volumes (CTVs). Data have emerged further informing nodal recurrence patterns. The objective of this study is to provide an updated prostate pelvic nodal consensus atlas. Methods and materials A literature review was performed abstracting data on nodal recurrence patterns. Data were presented to a panel of international experts, inclu...
19 CitationsSource
#1Shaista Hafeez (ICR: Institute of Cancer Research)H-Index: 13
#2Emma Patel (Mount Vernon Hospital)H-Index: 5
Last. Robert Huddart (ICR: Institute of Cancer Research)H-Index: 83
view all 10 authors...
Introduction Patients with muscle invasive bladder cancer (MIBC) who are unfit and unsuitable for standard radical treatment with cystectomy or daily radiotherapy present a large unmet clinical need. Untreated, they suffer high cancer specific mortality and risk significant disease-related local symptoms. Hypofractionated radiotherapy (delivering higher doses in fewer fractions/visits) is a potential treatment solution but could be compromised by the mobile nature of the bladder, resulting in ta...
15 CitationsSource
#1Robert Huddart (ICR: Institute of Cancer Research)H-Index: 83
#2Emma Hall (ICR: Institute of Cancer Research)H-Index: 57
Last. Bc InvestigatorsH-Index: 2
view all 13 authors...
Abstract Background BC2001, the largest randomised trial of bladder-sparing treatment for muscle-invasive bladder cancer, demonstrated improvement of local control and bladder cancer–specific survival from the addition of concomitant 5-fluorouracil and mitomycin C to radiotherapy. Objective To determine the impact of treatment on the health-related quality of life (HRQoL) of BC2001 participants. Design, setting, and participants 458 UK patients with T2-T4a N0 M0 transitional cell carcinoma of th...
22 CitationsSource
#1Alexander D. Sherry (Vandy: Vanderbilt University)H-Index: 5
#2Adam StewartH-Index: 1
Last. Austin N. Kirschner (VUMC: Vanderbilt University Medical Center)H-Index: 11
view all 4 authors...
Objective Intensity-modulated radiation therapy (IMRT) using a volumetric-modulated arc therapy technique may offer dosimetric and clinical benefits compared to the historical standard of care 3D conformal radiotherapy (3D-CRT) in definitive treatment of bladder cancer. We hypothesized that IMRT with CBCT would reduce dose to the rectum, bowel, and bladder compared to 3D-CRT.
3 CitationsSource
#1Gustavo Arruda Viani (USP: University of São Paulo)H-Index: 2
#2Ana Carolina Hamamura (USP: University of São Paulo)H-Index: 3
Last. Alexandre C Faustino (USP: University of São Paulo)H-Index: 2
view all 3 authors...
PURPOSE: To compare the treatment outcomes of a cohort of prostate cancer patients treated with conventional schedule using IMRT or 3DRT technique. MATERIALS AND METHODS: Between 2010-2017, 485 men with localized prostate cancer were treated with conventional radiotherapy schedule with a total dose ≥74Gy using IMRT (231) or 3DCRT (254). Late gastrointestinal (GI) and genitourinary (GU) toxicity were retrospectively evaluated according to modifi ed RTOG criteria. The biochemical control was defi ...
4 CitationsSource
#1Emma Patel (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 5
#2Y. Tsang (Mount Vernon Hospital)H-Index: 11
Last. Robert Huddart (The Royal Marsden NHS Foundation Trust)H-Index: 83
view all 11 authors...
Abstract Background and Purpose Hypofractionated bladder RT with or without image guided adaptive planning (HYBRID) is a multicentre clinical trial investigating “Plan of the Day” (PoD) adaptive radiotherapy for bladder cancer. To ensure correct PoD selection a pre-accrual guidance and assessment module was developed as part of an image guided radiotherapy quality assurance (IGRT QA) credentialing programme. This study aimed to evaluate its feasibility and effectiveness across multiple recruitin...
10 CitationsSource
Cited By1
Newest
#1Janice Yeh (Peter MacCallum Cancer Centre)
#2Mathias Bressel (Peter MacCallum Cancer Centre)H-Index: 26
Last. Farshad Foroudi (Austin Hospital)H-Index: 27
view all 5 authors...
Source